FrancophonIA/ELRC3.0 huggingface dataset:
English: You should take this medicine either with a light meal or without a meal once a day, preferably at the same time each day.
Croatian: Ovaj lijek trebate uzimati ili s laganim obrokom ili bez obroka jednom na dan, po mogućnosti svaki dan u isto vrijeme.
English: Method of administration Swallow the tablet whole with some water.
Croatian: Progutajte cijelu tabletu s nešto vode.
English: As for other medicinal products acting on the renin-angiotensin system, caution should be exercised when aliskiren is given in the presence of conditions pre-disposing to kidney dysfunction such as hypovolaemia (e.g. due to blood loss, severe prolonged diarrhoea, prolonged vomiting, etc.), heart disease, liver disease, diabetes mellitus or kidney disease.
Croatian: Kao i s drugim lijekovima koji djeluju na renin-angiotenzin sustav, nužan je oprez kada se aliskiren daje u stanjima s predispozicijom za disfunkciju bubrega kao što su hipovolemija (npr. zbog gubitka krvi, teškog ili produljenog proljeva, produljenog povraćanja, itd), bolest srca, bolest jetre, šećerna bolest ili bolest bubrega.
English: INFORMATION IN BRAILLE Rasilez 150 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Rasilez 150 mg
English: an angiotensin converting enzyme inhibitor such as enalapril, lisinopril, ramipril or an angiotensin II receptor blocker such as valsartan, telmisartan, irbesartan.
Croatian: inhibitor angiotenzin - konvertirajućeg enzima kao što je enalapril, lizinopril, ramipril ili blokator angiotenzin II receptora, kao što je valsartan, telmisartan, irbesartan.
English: You should take this medicine once a day, always with or always without food, preferably at the same time each day.
Croatian: Ovaj lijek trebate uzimati jednom na dan, uvijek sa ili uvijek bez hrane, po mogućnosti svaki dan u isto vrijeme.
English: A single dose interaction study in healthy subjects has shown that ciclosporin (200 and 600 mg) increases Cmax of aliskiren 75 mg approximately 2.5-fold and AUC approximately 5-fold.
Croatian: Ispitivanje interakcije lijekova uz primjenu jednokratne doze lijeka u zdravih ispitanika pokazalo je da ciklosporin (200 i 600 mg) povećava Cmax aliskirena u dozi od 75 mg otprilike 2,5 puta, a AUC otprilike 5 puta.
English: Rasilez 150 mg film-coated tablets EU/1/07/405/001-010
Croatian: Rasilez 150 mg filmom obložene tablete EU/1/07/405/001-010
English: The most common adverse reaction is diarrhoea.
Croatian: Najčešća nuspojava je proljev.
English: In another juvenile toxicity study in 14-day-old rats, aliskiren administration at 300 mg/kg/day (8.5-fold the maximum recommended human dose) was associated with delayed mortality.
Croatian: U drugom ispitivanju toksičnosti na mladim štakorima starosti od 14 dana, primjena aliskirena u dozi od 300 mg/kg/dan (8,5 puta više od najveće preporučene doze u ljudi) bila je povezana s odgođenim mortalitetom.
English: Angioedema, erythema Musculoskeletal and connective tissue disorders Common:
Croatian: Angioedem, eritem Poremećaji mišićno-koštanog sustava i vezivnog tkiva
English: - verapamil, a medicine used to lower high blood pressure, to correct heart rhythm or to treat angina pectoris.
Croatian: - ketokonazol, lijek koji se koristi za liječenje gljivičnih infekcija. - verapamil, lijek koji se koristi za snižavnje visokog krvnog tlaka, da se ispravi srčani ritam ili za liječenje angine pektoris.
English: If pregnancy is detected during therapy, treatment should be discontinued accordingly.
Croatian: Stoga, ako se tijekom terapije utvrdi trudnoća,
English: In clinical studies aliskiren has not been investigated in hypertensive patients with severe renal impairment (serum creatinine ≥ 150 μmol/l or 1.70 mg/dl in women and ≥ 177 μmol/l or 2.00 mg/dl in men and/or estimated GFR < 30 ml/min/1.73 m2), history of dialysis, nephrotic syndrome or renovascular hypertension.
Croatian: U kliničkim ispitivanjima aliskiren nije ispitivan u hipertenzivnih bolesnika s teškim oštećenjem bubrežne funkcije (kreatinin u serumu ≥150 μmol/l ili 1,70 mg/dl u žena, te ≥177 μmol/l ili 2,00 mg/dl u muškaraca i/ili procijenjena brzina glomerularne filtracije (GFR) <30 ml/min/1,73 m2), dijalizom,
English: Rasilez 150 mg film-coated tablets PA/Alu/PVC - Alu blisters:
Croatian: Rasilez 300 mg filmom obložene tablete PA/Al/PVC - Al blisteri:
English: Aliskiren was evaluated for cardiovascular and/or renal benefit in a double-blind placebo controlled randomised trial in 8,606 patients with type 2 diabetes and chronic kidney disease (evidenced by proteinuria and/or GFR < 60 ml/min/1.73 m2) with or without cardiovascular disease.
Croatian: Aliskiren je ocjenjivan s obzirom na kardiovaskularnu i/ili bubrežnu korist u dvostruko slijepom placebom kontroliranom randomiziranom ispitivanju u kojem je sudjelovalo 8606 bolesnika sa šećernom bolešću tip 2 i kroničnom bolešću bubrega (koja se dokazuje proteinurijom i/ili GFR-om <60 ml/min/1,73 m2) sa ili bez kardiovaskularne bolesti.
English: After single dose administration in the dose range of 75 to 600 mg, a 2-fold increase in dose results in a ~2.3 and 2.6-fold increase in AUC and Cmax, respectively.
Croatian: Nakon primjene jednokratne doze u rasponu doza od 75 do 600 mg, 2 puta povećanje doze rezultira ~2,3-, odnosno 2,6 puta povećanjem AUC-a, odnosno Cmax-a.
English: A number of these patients had a history of angioedema or symptoms suggestive of angioedema which in some cases was associated with the administration of other medicines known to cause angioedema, including RAAS blockers (ACEIs or ARBs).
Croatian: Određeni broj tih bolesnika imao je u anamnezi angioedem ili simptome koji upućuju na angioedem, čija je pojava u nekim slučajevima bila povezana s primjenom drugih lijekova za koje je poznato da uzrokuju angioedem, uključujući blokatore RAAS-a (ACEI-eve ili ARB-ove).
English: (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare
Croatian: Nuspojave lijeka su poredane prema učestalosti, pri čemu su najčešće navedene prve, na sljedeći način: vrlo često (≥1/10), često (≥1/100 i <1/10), manje često (≥1/1000 i <1/100), rijetko (≥1/10 000 i <1/1000), vrlo rijetko
English: The efficacy and safety of aliskiren-based therapy were compared to ramipril-based therapy in a 9-month non-inferiority study in 901 elderly patients (≥ 65 years) with essential systolic hypertension.
Croatian: Djelotvornost i sigurnost terapije temeljene na aliskirenu uspoređivana je s terapijom temeljenoj na ramiprilu u 9-mjesečnom ispitivanju neinferiornosti u kojem je sudjelovao 901 stariji bolesnik
English: - if you have already experienced angioedema (difficulties in breathing or swallowing, or swelling of the face, hands and feet, eyes, lips and/or tongue).
Croatian: - ako ste već imali angioedem (teškoće pri disanju ili gutanju, ili oticanje lica, ruku i nogu, očiju,
English: Consequently, no adjustment of the initial dose of aliskiren is required in patients with mild to severe hepatic impairment.
Croatian: Sukladno tome, nije potrebna prilagodba početne doze aliskirena u bolesnika s blagim do umjerenim oštećenjem jetrene funkcije.
English: Co-administration of Rasilez had no significant impact on atorvastatin, metformin or amlodipine pharmacokinetics.
Croatian: Istodobna primjena Rasileza nije imala značajan utjecaj na farmakokinetiku atorvastatina, metformina ili amlodipina.
English: Oral co-administration of aliskiren and furosemide had no effect on the pharmacokinetics of aliskiren but reduced exposure to furosemide by 20-30% (the effect of aliskiren on furosemide administered intramuscularly or intravenously has not been investigated).
Croatian: ali je smanjila izloženost furosemidu za 20-30% (učinak aliskirena na furosemid primijenjen intramuskularno ili intravenski nije bio ispitivan).
English: Consistent with standard medical practice, periodic determination of renal function including serum electrolytes is advised if co-administration is considered necessary.
Croatian: U skladu sa standardnom medicinskom praksom, ako se istodobna primjena lijekova smatra nužnom, savjetuje se periodičko određivanje funkcije bubrega, uključujući elektrolite u serumu.
English: In the majority of patients aged 65 years or older, the 300 mg dose of Rasilez shows no additional benefit in reducing blood pressure compared to the 150 mg dose.
Croatian: U većine bolesnika u dobi od 65 godina ili starijih, doza Rasileza od 300 mg ne pokazuje nikakvu dodatnu korist u snižavanju krvnog tlaka u usporedbi s dozom od 150 mg.
English: Hypersensitivity reactions including anaphylactic reactions and angioedema In controlled clinical studies, angioedema and hypersensitivity reactions occurred rarely during treatment with aliskiren with rates comparable to treatment with placebo or comparators.
Croatian: U kontroliranim kliničkim ispitivanjima angioedem i reakcije preosjetljivost javljali su se rijetko tijekom liječenja aliskirenom uz stope koje se mogu usporediti s liječenjem placebom ili komparatora.
English: In an 8-week randomised, double-blind study with aliskiren monotherapy in 267 paediatric hypertensive patients aged 6 to 17 years, mostly overweight/obese, fasting trough aliskiren concentrations at day 28 were comparable to those observed in other studies in both adults and children using similar aliskiren doses (see section 5.1).
Croatian: U 8-tjednom randomiziranom, dvostruko-slijepom ispitivanju monoterapije aliskirenom u 267 pedijatrijskih hipertenzivnih bolesnika u dobi od 6 do 17 godina, uglavnom s prekomjernom težinom/pretili, najniže vrijednosti koncentracije aliskirena natašte na dan 28 bile su usporedive s onima opaženima u drugim ispitivanjima i u odraslih i u djece koji su koristili slične doze aliskirena
English: When administered with atorvastatin, steady-state Rasilez AUC and Cmax increased by 50%.
Croatian: Kada je primijenjen s atorvastatinom, u dinamičke ravnoteže Rasileza AUC i Cmax povisili su se za 50%.
English: At steady state meals with low fat content reduce Cmax by 76% and AUC0-tau by 67% in hypertensive patients.
Croatian: Cmax za 76% i AUC0-tau za 67% u hipertenzivnih bolesnika.
English: In patients who did not adequately respond to 5 mg of the calcium channel blocker amlodipine, the addition of aliskiren 150 mg had a blood-pressure-lowering effect similar to that obtained by increasing amlodipine dose to 10 mg, but had a lower incidence of oedema (aliskiren 150 mg/amlodipine 5 mg 2.1% vs. amlodipine 10 mg 11.2%).
Croatian: dodatak aliskirena u dozi od 150 mg imao je učinak na sniženje krvnog tlaka koji je bio sličan učinku dobivenom povećanjem doze amlodipina na 10 mg, ali je incidencija edema bila niža (aliskiren 150 mg/amlodipin 5 mg 2,1% naspram amlodipina 10 mg 11,2%).
English: There was no significant benefit of adding aliskiren to enalapril (primary endpoint: hazard ratio of 0.93 with 95% Confidence Interval: 0.85-1.03; p=0.1724, combination versus enalapril).
Croatian: Nije bilo značajne koristi od dodavanja aliskirena enalaprilu (primarna mjera ishoda: omjer hazarda od 0,93 s intervalom pouzdanosti od 95%: 0,85-1,03; p=0,1724, kombinacija naspram enalapril).
English: Multipacks containing 280 (20x14) tablets.
Croatian: Višestruka pakiranja koja sadrže 280 (20x14) tableta.
English: 98 film-coated tablets (2x49x1)
Croatian: 98 filmom obloženih tableta (2x49x1)
English: - The concomitant use of Rasilez with an angiotensin converting enzyme inhibitor(ACEI) or an angiotensin II receptor blocker (ARB) is contraindicated in patients with diabetes mellitus or renal impairment (GFR < 60 ml/min/1.73 m2) (see sections 4.5 and 5.1).
Croatian: - Istodobna primjena Rasileza s inhibitorom angiotenzin-konvertirajućeg enzima (ACEI) ili blokatorom receptora angiotenzin II (ARB) kontraindicirana je u bolesnika sa šećernom bolešću ili oštećenjem bubrežne funkcije (GFR <60 ml/min/1,73 m2) (vidjeti dijelove 4.5 i 5.1).
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Croatian: 11. NAZIV I ADRESA NOSITELJA ODOBRENJA ZA STAVLJANJELIJEKA
English: Multipacks containing 98 (2x49x1) tablets in perforated unit dose blisters.
Croatian: Višestruka pakiranja koja sadrže 98 (2x49x1) tableta u perforiranim blisterima s jediničnim dozama.
English: Co-administration of ketoconazole (200 mg) or verapamil (240 mg) with aliskiren (300 mg) resulted in a 76% or 97% increase in aliskiren AUC, respectively.
Croatian: Umjereni P-gp inhibitori Istodobna primjena ketokonazola (200 mg) ili verapamila (240 mg) s aliskirenom (300 mg) rezultirala je 76%-im odnosno 97%-im povećanjem AUC-a aliskirena.
English: Rasilez may be used alone or in combination with other antihypertensive agents with the exception of use in combination with angiotensin converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB) in patients with diabetes mellitus or renal impairment (glomerular filtration rate (GFR) < 60 ml/min/1.73 m2) (see sections 4.3, 4.4 and 5.1).
Croatian: Rasilez se može primjenjivati sam ili u kombinaciji s drugim antihipertenzivnim lijekovima izuzimajući primjenu u kombinaciji s inhibitorima angiotenzin konvertirajućeg enzima (ACEI) ili blokatorima angiotenzina II receptora (ARB) u bolesnika sa šećernom bolešću ili oštećenjem bubrežne funkcije (brzina glomerularne filtracije (GFR) <60 ml/min/1,73 m2) (vidjeti dijelove 4.3, 4.4 i 5.1).
English: Warfarin The effects of aliskiren on warfarin pharmacokinetics have not been evaluated.
Croatian: Nisu ispitivani učinci aliskirena na farmakokinetiku varfarina.
English: However, the significance of the non-inferiority testing was not maintained when the analysis was performed on the per-protocol set in which the least square mean change in msSBP from baseline was -7.84 mmHg with aliskiren and -9.04 mmHg with enalapril.
Croatian: Međutim, značajnost za test neinferiornosti nije zadržana kad je analiza provedena na uzorku bolesnika liječenih prema protokolu, gdje je srednja vrijednost promjene srednjih vrijednosti sistoličkog krvnog tlaka u sjedećem položaju u odnosu na početne vrijednosti, procijenjena metodom najmanjih kvadrata, bila -7,84 mmHg s aliskirenom i -9,04 mmHg s enalaprilom.
English: - furosemide or torasemide, medicines belonging to the type known as diuretics, or “water”
Croatian: nadomjestke kalija. - furosemid ili torasemid, lijekove koji pripadaju skupini poznatoj kao diuretici ili „tablete za mokrenje“, koje se koriste za povećanje količine mokraće koju stvarate.
English: Co-administration of orange or apple juice with aliskiren 150 mg resulted in a 62% decrease in aliskiren AUC or in a 63% decrease in aliskiren AUC, respectively.
Croatian: Istodobna primjena soka od naranče ili jabuke s aliskirenom 150 mg rezultirala je smanjenjem AUC-a aliskirena za 62% odnosno smanjenjem AUC-a aliskirena za 63%.
English: In post-marketing experience, renal dysfunction and cases of acute renal failure have been reported in patients at risk (see section 4.4).
Croatian: Nakon stavljanja lijeka u promet u rizičnih bolesnika prijavljena je disfunkcija bubrega i slučajevi akutnog zatajivanja bubrega (vidjeti dio 4.4).
English: In the majority of patients aged 65 years or older, the 300 mg dose of aliskiren shows no additional benefit in reducing blood pressure compared to the 150 mg dose.
Croatian: U većine bolesnika u dobi od 65 godina ili starijih, doza aliskirena od 300 mg ne pokazuje nikakvu dodatnu korist u snižavanju krvnog tlaka u usporedbi s dozom od 150 mg.
English: 56 x 1 film-coated tablet
Croatian: 56 x 1 filmom obloženih tableta
English: 90 film-coated tablets (3x30)
Croatian: 90 filmom obloženih tableta (3x30)
English: Results from an in vitro MDR1 human tissue study suggested an age and tissue dependent pattern of MDR1 (P-gp) transporter maturation.
Croatian: Rezultati iz in vitro ispitivanja MDR1 u ljudskom tkivu ukazali su na obrazac sazrijevanja MDR1 (P
English: 280 film-coated tablets (20x14)
Croatian: 280 filmom obloženih tableta (20x14)
English: Common (may affect up to 1 in 10 people): Diarrhoea, joint pain (arthralgia), high level of potassium in the blood, dizziness.
Croatian: Često (mogu se javiti u do 1 na 10 osoba): Proljev, bol u zglobovima (artralgija), povišena razina kalija u krvi, omaglica.
English: Unit packs containing 56x1 tablets in perforated unit dose blisters.
Croatian: Jedinična pakiranja koja sadrže 56x1 tabletu u perforiranim blisterima s jediničnim dozama.
English: The usual recommended starting dose of aliskiren in elderly patients is 150 mg.
Croatian: Uobičajena početna doza aliskirena koja se preporučuje u starijih bolesnika iznosi 150 mg.
English: If co-administration with an agent affecting the level of serum potassium is considered necessary, routine monitoring of potassium levels would be advisable.
Croatian: Ako se istodobna primjena s lijekom koji utječe na razinu kalija u serumu smatra nužnom, savjetuje se redovno praćenje razina kalija.
English: No effect on QT interval was reported in a randomised, double-blind, placebo, and active-controlled study using standard and Holter electrocardiography.
Croatian: U randomiziranom, dvostruko-slijepom, placebom i aktivno kontroliranom kliničkom ispitivanju, u kojem je korištena standardna i Holter elektrokardiografija, nije prijavljen učinak na QT-interval.
English: Increases in serum potassium have been observed with aliskiren in post-marketing experience and these may be exacerbated by concomitant use of other agents acting on the RAAS or by non-steroidal anti-inflammatory drugs (NSAIDs).
Croatian: Nakon stavljanja aliskirena u promet opažena su povišenja kalija u serumu, što može biti pogoršano istodobnom primjenom drugih lijekova koji djeluju na RAAS ili nesteroidnih prouupalnih lijekova (NSAIL-ova).
English: Combination therapy studies are available for aliskiren added to the diuretic hydrochlorothiazide, the calcium channel blocker amlodipine and the beta blocker atenolol.
Croatian: blokatoru kalcijevih kanala amlodipinu i beta-blokatoru atenololu.
English: Rasilez 150 mg film-coated tablets are available in the following packs: - Unit packs containing 7, 14, 28, 30, 50, 56, 90 or 98 tablets - Unit packs containing 56x1 tablets in perforated unit-dose blisters - Multipacks containing 84 (3x28), 98 (2x49) or 280 (20x14) tablets - Multipacks containing 98 (2x49x1) tablets in perforated unit-dose blisters
Croatian: Rasilez 150 mg filmom obložene tablete su dostupne u sljedećim pakiranjima: - Jedinična pakiranja koja sadrže: 7, 14, 28, 30, 50, 56, 90 ili 98 tableta - Jedinična pakiranja koja sadrže 56x1 tableta u perforiranim blisterima s jediničnim dozama
English: 84 film-coated tablets (3x28)
Croatian: 84 filmom obložene tablete (3x28)
English: Aliskiren should be used with caution in patients with serious congestive heart failure (New York Heart Association (NYHA) functional class III-IV) (see section 5.1).
Croatian: York Heart Association (NYHA) funkcionalni stupanj III-IV) (vidjeti dio 5.1).
English: After multiple doses of furosemide (60 mg/day) co-administered with aliskiren (300 mg/day) to patients with heart failure the urinary sodium excretion and the urine volume were reduced during the first 4 hours by 31% and 24%, respectively, as compared to furosemide alone.
Croatian: primijenjenih istodobno s aliskirenom (300 mg/dan) bolesnicima sa zatajanjem srca izlučivanje natrija mokraćom i volumen mokraće bili su smanjenji tijekom prva 4 sata za 31% odnosno za 24%, u usporedbi s bolesnicima koji su primali furosemid zasebno.
English: Aliskiren was not teratogenic in rats or rabbits (see section 5.3).
Croatian: Aliskiren nije bio teratogen u štakora ili kunića
English: The incidence of adjudicated stroke was not significantly different between the aliskiren and enalapril groups (4.4% versus 4.0%; HR 1.12, 95% CI 0.848, 1.485) or between the combination and enalapril groups (3.7% versus 4.0%; HR 0.93, 95% CI 0.697, 1.251).
Croatian: Incidencija utvrđenog moždanog udara nije bila značajno različita između skupine na aliskirenu i one na enalaprilu (4,4% naspram 4,0%; omjer hazarda 1,12; interval pouzdanosti od 95% 0,848, 1,485) ili između skupine na kombinaciji odnosno enalaprilu (3,7% naspram 4,0%; omjer hazarda 0,93; interval pouzdanosti od 95% 0,697,
English: PHARMACEUTICAL FORM AND CONTENTS Multipack: 280 (20 packs of 14) film-coated tablets Multipack: 98 (2 packs of 49 x 1) film-coated tablets
Croatian: OBLIK I SADRŽAJ Višestruko pakiranje: 280 (20 pakiranja od 14) filmom obloženih tableta Višestruko pakiranje: 98 (2 pakiranja od 49 x 1) filmom obloženih tableta
English: However, since aliskiren has been shown to be a substrate for the organic anion-transporting polypeptide 1A2 (OATP1A2) (see section “Organic anion transporting polypeptide (OATP” below) inhibitors), there is a potential for aliskiren to reduce plasma torasemide exposure by an interference with the absorption process.
Croatian: Međutim, budući da se pokazalo da je aliskiren supstrat za polipeptidni prijenosnik organskih aniona 1A2 (OATP1A2) (vidjeti dio
English: Optional titration of the respective study drug doses to the next highest weight-based dose level was available by doubling the dose with each of the two allowed dose titrations, up to 600 mg (highest studied dose in adults) for aliskiren and 40 mg for enalapril in the ≥80 to ≤150 kg weight group, if medically necessary to control the mean sitting systolic blood pressure (i.e. msSBP should be less than the 90th percentile for age, gender and height).
Croatian: Titracija doza ispitivanog lijeka na sljedeću najvišu razinu doze temeljene na tjelesnoj težini bila je dostupna udvostručenjem doze sa svakom od dvije dopuštene titracije doze, do 600 mg (najviša ispitivana doza u odraslih) za aliskiren i 40 mg za enalapril u grupi tjelesne težine ≥80 do ≤150 kg, ako je bilo medicinski neophodno za kontrolu srednje vrijednosti sistoličkog krvnog tlaka u sjedećem položaju (tj. srednja vrijednost sistoličkog krvnog tlaka u sjedećem položaju treba biti niža od 90-e percentile za dob, spol i visinu).Ukupno, srednja dob bolesnika bila je 11,8 godina s 48,6% bolesnika u dobnoj skupini od 6-11 godina i 51,4% u dobnoj skupini od 12-17 godina.
English: The pharmacokinetics of aliskiren were evaluated in patients with end stage renal disease receiving haemodialysis.
Croatian: Farmakokinetika aliskirena bila je ocjenjivana u bolesnika na hemodijalizi u završnom stadiju bubrežne bolesti.
English: No overall clinically relevant adverse impact on paediatric patients aged 6 to 17 years was observed after treatment with aliskiren for up to one year based on physical development, assessed in patients with primary or secondary hypertension, and neurocognitive development assessed only in patients with secondary hypertension (19 patients: 9 previously treated with aliskiren and 10 previously treated with enalapril) (see section 4.2, 4.8, 5.1 and 5.2).
Croatian: ocijenjenog u bolesnika s primarnom ili sekundarnom hipertenzijom i neurokognitivnog razvoja ocijenjenog samo u bolesnika sa sekundarnom hipertenzijom (19 bolesnika: 9 prethodno liječenih aliskirenom i 10 prethodno liječenih enalaprilom) (vidjeti dijelove 4.2, 4.8, 5.1 i 5.2).
English: In a juvenile toxicity study in 8-day-old rats, aliskiren administration at 100 mg/kg/day and 300 mg/kg/day (2.3- and 6.8-fold the maximum recommended human dose) was associated with high mortality and severe morbidity.
Croatian: 100 mg/kg/dan i 300 mg/kg/dan (2,3 i 6,8 puta više od najveće preporučene doze u ljudi) bila je povezana s visokim mortalitetom i teškim morbiditetom.
English: Mean weight was 68.0 kg with 57.7% of patients having BMI greater than or equal to the 95th percentile for age and gender.
Croatian: Srednja tjelesna težina je bila 68,0 kg s 57,7% bolesnika s indeksom tjelesne mase (BMI, engl.
English: 98 film-coated tablets (2x49)
Croatian: 98 filmom obloženih tableta (2x49)
English: These observed changes, however, did not correlate with the severity of renal impairment.
Croatian: Ove opažene promjene nisu bile u korelaciji s težinom oštećenja bubrežne funkcije.